References
- Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585–91
- Lacomblez L., Bensimon G., Leigh P. N., Guillet P., Meininger V. Dose‐ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996; 347: 1425–31
- Sanderink G. J., Bournique B., Stevens J., Petry M., Martinet M. Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. J Pharmacol Exp Ther 1997; 282: 1465–72
- Groeneveld G. J., van Kan H. J., Torano J. S., Veldink J. H., Guchelaar H. J., Wokke J. H. J., et al. Inter‐ and intra‐individual variability of riluzole serum concentrations in patients with ALS. J Neurol Sci 2001; 191: 121–5
- van Kan H. J., Groeneveld G. J., Kalmijn S., Spieksma M., van den Berg L. H., Guchelaar H. J. Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis. Br J Clin Pharmacol 2005; 59: 310–3
- Sachse C., Bhambra U., Smith G., Lightfoot T. J., Barrett J. H., Scollay J., et al. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 2003; 55: 68–76
- Brooks B. R., Miller R. G., Swash M., Munsat T. L., World federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–9
- Colovic M., Zennaro E., Caccia S. Liquid chromatographic assay for riluzole in mouse plasma and central nervous system tissues. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 803: 305–9
- Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 1989
- Sachse C., Brockmoller J., Bauer S., Roots I. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999; 47: 445–9
- Corchero J., Pimprale S., Kimura S., Gonzalez F. J. Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics 2001; 11: 1–6
- Ueda R., Iketaki H., Nagata K., Kimura S., Gonzalez F. J., Kusano K., et al. A common regulatory region functions bi‐directionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes. Mol Pharmacol 2006; 69: 1924–30
- Le Liboux A., Cachia J. P., Kirkesseli S., Gautier J. Y., Guimart C., Montay C., et al. A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose administration in healthy elderly and young volunteers. J Clin Pharmacol 1999; 39: 480–6
- Remy A. J., Camu W., Ramos J., Blanc P., Larrey D. Acute hepatitis after riluzole administration. J Hepatol 1999; 30: 527–30